Archive for the ‘Uncategorized’ Category

Parental Rights in Medical Settings

http://www.parentalrights.org

Over the last couple of decades we have seen the emergence of a lobby that believes in giving power to “experts” to seek the good of all children. Nevertheless parents continue to defend their right to make the best individualized decisions for their child. We are seeing that tension between parent and professional become more entrenched each year.

This year has seen a rise in the number of appeals in which an earlier guilty verdict from a charge of “shaken baby syndrome” or “medical child abuse” has been thrown out. These appeals are rising as reports and expert witnesses show flaws in the science behind those convictions. Parent and child advocates like Diane Redleaf at the Family Defense Center in Chicago and law professor Maxine Eichner at the University of North Carolina are exposing the legal and ethical issues that arise when doctors act in a forensic role (gathering evidence against parents) rather than in the traditional care-giving role of their field.

Parents and children infected with tick borne illness (TBI’s), understand this all too well.  Due to a schism in the medical community over proper diagnosis and treatment – patients are the ones who suffer.  Parents are often told by the mainstream medical community that they have Munchausen by proxy, a psychological disorder marked by attention-seeking behavior by a caregiver through those who are in their care.  Children having a difficult time in school are told they are “lazy,” or “bored” and they just need to buckle down and work harder.

In other words – parents and children with TBI’s are frequently told they are just making up symptoms to get attention.  

Having lived this nightmare on steroids for over 4 years, I can attest to the mental anguish, out of pocket expense, marital/familial strife, and pain Lyme/MSIDS (multiple systemic infectious disease syndrome – or Lyme with coinfections as many have far more than just borrelia the causative agent of Lyme Disease) causes.  

Solution: The Parental Rights Amendment

A proposed Parental Rights Amendment to the U.S. Constitution (PRA) would provide that “the liberty of parents to direct the upbringing, education, and care of their children is a fundamental right.” By setting a firm constitutional standard to protect these rights, the Amendment would provide clear direction for courts, doctors, child welfare workers, and other government officials. Racial bias would diminish as fewer cases are left to the discretion of a judge or other state agent.

Another provision of the proposed Amendment would protect the rights of persons with disabilities so that mothers like Sara Gordon never lose their children in the first place. The proposal states, “The parental rights guaranteed by this article shall not be denied or abridged on account of disability.”

The attack on parents in America continues. The PRA provides the single greatest means for parents to fight back – and win.

Sadly, medical error is the #3 cause of death in our country according to a 2016 report. And even the best doctors are rarely in a better position than a loving parent to make the difficult decisions for a child.

Most recently is the case of Charlie Gard of the United Kingdom whose parents raised $1.6 million in private funds to transport him to the U.S. for further care but the state hospital has been granted the legal right to pull the plug on the disabled infant at any time.

What happens in Europe has a way of coming here, and way has been paved due to the Supreme Court’s Troxel v. Granville (2000) decision.  Where once parental rights were afforded “strict judicial scrutiny” protection (Troxel, p. 80), now those same rights are granted only “some special weight” (ibid., p. 70)—and what that means varies from judge to judge and case to case.

Right here in the U.S., the family of Justina Pelletier found that out the hard way in 2014 when the state of Massachusetts took Justina from them and placed her in the custody of Boston Children’s Hospital. Doctors there were free to enroll her in clinical trials (without parental consent) for the somatoform disorder diagnosis they had given her, rather than continuing the treatment for Mitochondrial disease that her parents and doctors at Tufts Medical Center had been following. After public outrage following her parents going public, Justina was finally returned to her parents 16 months later, in much worse condition than when she was taken away. Her story reemerged in 2016 as the family filed suit in federal court against the state and the hospital who so severely injured their daughter.
Isaiah Rider of Missouri was also taken by the state over a disagreement regarding his treatment. He was finally released by the state of Illinois who had been granted custody (though he was never a resident of the state until he went into foster care) when Lurie Children’s Hospital (Chicago) doctors decided they knew better than his mom. While in foster care, Rider suffered sexual assault. He was finally returned to the custody of his grandparents in his home state, but wasn’t fully released from Illinois care until June of 2016, months after his 18th birthday!

As sad as it sounds, though, the Riders and the Pelletiers are the lucky ones. A family in New York found themselves facing allegations of child abuse after their infant died at the hands of New York doctors, according to a lawsuit filed last year. The suit alleges that the Long Island infant was pumped full of a “cornucopia of drugs,” including Propofol, “the powerful sedative linked to Michael Jackson’s death” according to a NY Post article. As the baby lay dying, Suffolk County social workers and a “pediatric child abuse specialist” were accusing the parents of shaking her to death, a charge the parents contend was fabricated to cover up the hospital’s own serious errors in the child’s treatment. The couple’s two older children were taken from their care, but returned after two autopsies of the baby showed no signs of criminality. The child protection agency kept its case open for 11 long months, and is now a codefendant in the suit.

Two other cases, one in California and another in Tennessee, also saw the state take children away from loving parents over a disagreement in the child’s diagnosis and treatment.

Yet even as the evidence is showing more and more the fallibility of the medical profession, states are heeding doctors’ and pharmaceutical companies’ urgings to clamp down on parents’ rights in medical decisions. California in 2015 notoriously passed SB 277, a bill to remove from parents the right to make an informed medical decision regarding their child’s vaccinations. https://madisonarealymesupportgroup.com/2015/07/15/vaccines-continued/   Similar bills were introduced in 19 other states but failed to pass. Proponents of these bills, though, are undeterred, as evidenced by the number of states dealing with similar measures again this legislative session – already as many as 30.

In the medical sub-category of psychotropic drugs, parental rights have seen a slight improvement. Though most psychotropic drugs are not approved by the FDA for use by adolescents, many localities have nevertheless required their prescription to students who misbehave in school. Maryanne Godboldo of Detroit made national headlines 3 years ago when she barricaded herself and her daughter in her apartment and refused to let the city force her 13-year-old to receive Risperdol. The ensuing standoff brought out the SWAT team, a tank, and the national news.  Maryanne’s own case was finally resolved this year when charges – which had been filed or appealed 5 separate times – were finally dropped. Sadly, they were dropped only because Godboldo suffered a massive aneurysm and is not expected to recover from her current comatose state.

But in the state of New Mexico, real progress has been made. That state in 2015 passed a law prohibiting a parent’s choice to withhold psychotropic medications from being used as the sole basis for removal of a child. A New Mexico mother in Godboldo’s situation will no longer have to barricade herself in her home in the first place. If she determines that Risperdol is dangerous, that New Mexico mom can rest easy in the knowledge that no one will be coming for her child.

If you and/or your children have Lyme/MSIDS and you need legal help, contact:  mailto://info@parentalrights.org and ask for the list of legal organizations who will be able to help you.

ParentalRights.org is a 501(c)4 non-profit political lobbying organization whose goal is to protect children by empowering parents through passage of the Parental Rights Amendment to the U.S. Constitution. They do not provide legal help, nor do they have lawyers on staff.  However, they will help you find help.

 

More CDC Overreach – Quaranteened for a Cold

http://www.thevaccinereaction.org/2017/02/cdc-publishes-final-rule-on-quarantine-powers/  Article in full here by Dr. Mercola, guest writer

On the last day of the Obama administration, a final rule was issued by the CDC giving them expanded authority to quarantine for at least 72 hours a person entering the U.S. or even traveling between states who is suspected or at risk for cholera, plague, diphtheria, smallpox, yellow fever, infectious tuberculosis, viral hemorrhagic fevers, severe acute respiratory syndrome and influenza.  

The new rule also allows for federal surveillance of travelers for non-quarantinable diseases like measles, pertussis and meningococcal disease.  

Over 15,000 public comments were given expressing concern of governmental overreach, which the CDC denied but did serve to eliminate the part that people would be forced to submit to hospitalization, vaccination, and medical treatment, and that medical examination can only be done with informed consent.  

What symptoms could cause containment?

*fever

*headache

*cramps

*loose stools

*vomiting

*possibly rashes and coughing

Pilots and ship operators also need to report signs and symptoms of sick travelers to the CDC before arriving into the U.S.

Pilots need to report:

  1. Fever (100.4 F or greater), feels warm to the touch or gives history of feeling feverish and one of the following:

*Skin Rash

*Difficulty breathing

*Persistent cough

*Decreased consciousness or confusion

New unexplained bleeding or bruising

*Persistent diarrhea

*Persistent vomiting

*Headache with stiff neck

*Appearing unwell; OR

2.  Fever that has persisted more than 48 hours; OR

3.  Other symptoms in the Federal Register

Ship Operators are to report similar symptoms with the addition of:

Acute gastroenteritis defined as 3 or more episodes of diarrhea within 24 hours, and vomiting with one or more of the following:  1 or more episodes of diarrhea in a 24-hour period, abdominal cramps, headache, muscle aches or fever OR other symptoms in the Federal Register.

New regulations will not take effect until at least the end of March, 2017.

 

Grant to Study How Bb Survives Hostile Environment

https://www.eurekalert.org/pub_releases/2017-02/uota-upr020217.php

PUBLIC RELEASE: 2-FEB-2017
UTSA professor receives grant to study how Lyme disease survives in hosts

UNIVERSITY OF TEXAS AT SAN ANTONIO

Janakiram Seshu, associate professor of biology and associate dean of The Graduate School at The University of Texas at San Antonio (UTSA), has received a $404,250 grant from the National Institute of Allergy and Infectious Disease to support his research to better understand and prevent the spread of Lyme disease.

“Dr. Seshu’s top-tier efforts in infectious disease research are a source of immense pride for the UTSA College of Sciences,” said George Perry, Semmes Foundation Distinguished University Chair in Neurobiology and dean of the UTSA College of Sciences. “His work will undoubtedly have a great impact on our knowledge of Lyme disease, as well as our efforts to fight it.”

“As Lyme disease-carrying ticks increasingly spread to new areas of the country, we need to improve our understanding of the disease. Dr. Seshu’s bacteria research will help us limit Lyme disease’s spread and allow folks here in Texas and across the nation to live healthier lives,” said U.S. Representative Joaquin Castro. “Thanks to UTSA’s continued leadership, science thrives in San Antonio.”

Seshu, a member of the South Texas Center for Emerging Infectious Diseases, is best known by his peers for his inventive approach to stop the spread of Lyme disease. His work, described in a recent paper, leverages medication that is normally used to lower cholesterol.

“As a member of The South Texas Center for Emerging Infectious Diseases (STCEID), Dr. Seshu’s work is always interesting and innovative. With Lyme disease-carrying ticks now present in over half the country, his research and findings will provide new insights in the treatment against the particular bacterium,” said Bernard Arulanandam, UTSA interim vice president for research.

The big question at the heart of Seshu’s research is how the bacterium that causes Lyme disease, called Borrelia burgdorferi, is able to adapt to its immediate environment inside the tick vector or infected mammalian hosts. Mammalian bodies are very rich in nutrients and fatty acids, which make it very easy for the bacteria to thrive. The tick’s body is very different. It’s very poor in nutrients. Yet the bacterium adapts very quickly and allows the disease to spread.

To limit the transmission of the disease, Seshu’s entire laboratory is focused on understanding how the Lyme disease-carrying bacterium can reinvent itself to live for so long in such a disagreeable environment.

“This award from the National Institute of Allergy and Infectious Disease is an exciting investment to tackle a major debilitating disease in the US,” Seshu said. “I’m looking forward to advancing our understanding of this disease, so we can start finding better solutions.”

 

Lyme Patients Denied Care & Insurance Coverage – no Codes

http://www.prnewswire.com/news-releases/global-network-on-institutional-discrimination-lyme-disease-patients-denied-care-and-insurance-coverage-because-of-missing-diagnostic-codes-300403749.html

The World Health Organization (WHO) has over 68,000 diagnostic codes for illnesses, but Lyme symptoms aren’t listed, making Lyme patients invisible.

But, Jenna Luche-Thayer, Director of the Global Network on Institutional Discrimination, is hoping to change all that.  Thayer has requested a meeting with the WHO to modernize the Lyme Disease diagnostic codes.

Lyme Disease Biobank

https://www.eurekalert.org/pub_releases/2017-01/ts-nnl012317.php

PUBLIC RELEASE: 24-JAN-2017

New national Lyme Disease Biobank to accelerate research by making samples available

Qualified researchers now have one-stop access to patient samples from Long Island, San Francisco Bay Area, Martha’s Vineyard, and Marshfield, Wisc.

BAY AREA LYME FOUNDATION
Portola Valley, Calif., Jan. 24, 2017 – Bay Area Lyme Foundation, a national organization funding research to make Lyme disease easy to diagnose and simple to cure, announces the launch of the Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with acute Lyme disease from multiple regions across the country, including the East Coast, West Coast and Upper Midwest.

“One of the biggest barriers to research is a lack of samples from people confirmed to have Lyme disease – our program aims to alleviate this,” said Liz Horn, PhD, MBI, principal investigator, Lyme Disease Biobank. “Our efforts will unlock a huge bottleneck and make it possible for more scientists to conduct desperately needed research in Lyme disease.”

The Lyme Disease Biobank will dramatically increase the volume of well-characterized samples to enable research efforts to accelerate medical breakthroughs in the understanding, diagnosis and treatment of Lyme disease as well as co-infections. More than 95% of Lyme disease researchers (n=50) reported that they do not have access to the samples they need for their research, according to a 2016 survey conducted by Lyme Disease Biobank.

Because the bacterial strains which cause many tick-borne infections have been shown to vary from region to region, the Lyme Disease Biobank offers researchers the unique opportunity to explore potential new diagnostics against a range of bacterial strains. Samples from patients and healthy controls are currently available from East Hampton, New York, Martha’s Vineyard, Mass., and Marshfield, Wisc., and collections will soon become available from centers in the San Francisco Bay Area, Calif. Each sample undergoes several tests, including Serology (ELISA, Western Immunoblot IgM/IgG; C6 Peptide) and PCR, in order to confirm the diagnosis of Lyme disease and any co-infections (or for the controls, to rule out a diagnosis). Currently there are samples available from more than 250 individual participants.

Each application for samples from researchers undergoes a peer-review process by three members of the Lyme Disease Biobank reviewer pool, which consists of 39 scientists and clinicians each with specific expertise related to tick-borne illness. The Lyme Disease Biobank Board will use the recommendations of these experts and the Principal Investigator to determine allocation of samples. Approvals will be based on technical merit, potential to advance diagnostics, the likelihood of increasing understanding of Lyme disease and other tick-borne infections, and alignment with the Lyme Disease Biobank scientific goals and objectives. Nine investigators have thus far been approved to receive samples.

Lyme Disease Biobank is fully supported by Bay Area Lyme Foundation, which has received several substantial grants that help fund this effort. Bay Area Lyme Foundation’s financial commitment has included: investigations and research to develop criteria for collections and distribution of samples; identification of appropriate initial locations and initiation of collections at pilot sites; enrollment of clinical participants at multiple sites; collection and storage of samples; sample testing; maintenance of the proper environment for samples; and appropriate follow-up on research to ensure completion and scientific collaboration as appropriate. Researchers approved to receive samples are required to pay a nominal fee for samples to cover the cost to retrieve and ship the requested samples.

About Lyme Disease Biobank

Launched in 2015, the Lyme Disease Biobank is collecting human biological samples, including blood and urine samples, from people with early suspected Lyme disease or other tick-borne infections, as well as people who have never had Lyme disease as the control group. The Lyme Disease Biobank is a Type I supporting organization of Bay Area Lyme Foundation. Researchers interested in obtaining samples should visit http://www.lymebiobank.org.

About Lyme disease

One of the most common infectious diseases in the country, Lyme disease is a potentially debilitating infection caused by bacteria transmitted through the bite of an infected tick to people and pets. If caught early, most cases of Lyme disease can be effectively treated, but it is commonly misdiagnosed due to lack of awareness and unreliable diagnostic tests. There are about 329,000 new cases of Lyme disease each year, according to statistics released in 2015 by the CDC. As a result of the difficulty in diagnosing and treating Lyme disease, as many as one million Americans may be suffering from the impact of its debilitating long-term symptoms and complications, according to Bay Area Lyme Foundation estimates.

About Bay Area Lyme Foundation

Bay Area Lyme Foundation, a national organization committed to making Lyme disease easy to diagnose and simple to cure, is the leading public not-for-profit sponsor of innovative Lyme disease research in the US. A 501c3 non-profit organization based in Silicon Valley, Bay Area Lyme collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment are common knowledge.

A pivotal donation from The Laurel Foundation covers all overhead costs and allows for 100% of all donor contributions to Bay Area Lyme Foundation to go directly to research and prevention programs. For more information about Lyme disease or to get involved, visit http://www.bayarealyme.org or call us at 650-530-2439.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.